You are here
NEW ENGLAND BIOLABS, INC.
UEI: EDKJNT8DADG8
# of Employees: 489
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Structure guided rational engineering of novel DNA reagents.
Amount: $99,781.00DESCRIPTION (provided by applicant): Type II restriction enzymes (REases) are indispensible tools of modern medical research. It has long been a goal of REase manufacturers to be able to offer program ...
STTRPhase I2013Department of Health and Human Services National Institutes of Health -
Structure guided rational engineering of novel DNA reagents.
Amount: $761,592.00DESCRIPTION (provided by applicant): Type II restriction enzymes (REases) are indispensible tools of modern medical research. It has long been a goal of REase manufacturers to be able to offer program ...
STTRPhase II2013Department of Health and Human Services National Institutes of Health -
Novel 5-methylcytosine Oxidases
Amount: $251,006.00DESCRIPTION: With the recent discovery of 5-hydroxymethylcytosine in mammalian DNA and the TET enzyme family responsible for its generation, it is clear that the mammalian DNA epigenome is much more c ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Studies of DNA Methyltransferases
Amount: $1,002,120.00DESCRIPTION (provided by applicant): This project takes advantage of a DNA sequencing technology newly developed by Pacific Biosciences called SMRT sequencing. In addition to providing the DNA base se ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct
Amount: $960,499.00DESCRIPTION (provided by applicant): Directed protein evolution is a powerful technology for protein engineering. It generally involves generating a library of protein variants and identifying those w ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES.
Amount: $640,759.00DESCRIPTION (provided by applicant): It is recently discovered that a significant portion of the modified cytosines in mammalian genomes is 5-hydroxymethylcytosine (5-hmC), an oxidation product of 5- ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
Amount: $874,892.00DESCRIPTION (provided by applicant): This project aims to find novel restriction enzymes that will be useful in many aspects of molecular biology research. One particular focus will be on restriction ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES.
Amount: $278,797.00DESCRIPTION (provided by applicant): It is recently discovered that a significant portion of the modified cytosines in mammalian genomes is 5-hydroxymethylcytosine (5-hmC), an oxidation product of 5- ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
Amount: $218,685.00DESCRIPTION (provided by applicant): This project aims to find novel restriction enzymes that will be useful in many aspects of molecular biology research. One particular focus will be on restriction ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
Studies of DNA Methyltransferases
Amount: $256,651.00DESCRIPTION (provided by applicant): This project takes advantage of a DNA sequencing technology newly developed by Pacific Biosciences called SMRT sequencing. In addition to providing the DNA base se ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health